Cargando…

Deep Learning Based Drug Metabolites Prediction

Drug metabolism research plays a key role in the discovery and development of drugs. Based on the discovery of drug metabolites, new chemical entities can be identified and potential safety hazards caused by reactive or toxic metabolites can be minimized. Nowadays, computational methods are usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Disha, Liu, Wenjun, Shen, Zihao, Jiang, Lei, Wang, Jie, Li, Shiliang, Li, Honglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003989/
https://www.ncbi.nlm.nih.gov/pubmed/32082146
http://dx.doi.org/10.3389/fphar.2019.01586
_version_ 1783494638134362112
author Wang, Disha
Liu, Wenjun
Shen, Zihao
Jiang, Lei
Wang, Jie
Li, Shiliang
Li, Honglin
author_facet Wang, Disha
Liu, Wenjun
Shen, Zihao
Jiang, Lei
Wang, Jie
Li, Shiliang
Li, Honglin
author_sort Wang, Disha
collection PubMed
description Drug metabolism research plays a key role in the discovery and development of drugs. Based on the discovery of drug metabolites, new chemical entities can be identified and potential safety hazards caused by reactive or toxic metabolites can be minimized. Nowadays, computational methods are usually complementary tools for experiments. However, current metabolites prediction methods tend to have high false positive rates with low accuracy and are usually only used for specific enzyme systems. In order to overcome this difficulty, a method was developed in this paper by first establishing a database with broad coverage of SMARTS-coded metabolic reaction rule, and then extracting the molecular fingerprints of compounds to construct a classification model based on deep learning algorithms. The metabolic reaction rule database we built can supplement chemically reasonable negative reaction examples. Based on deep learning algorithms, the model could determine which reaction types are more likely to occur than the others. In the test set, our method can achieve the accuracy of 70% (Top-10), which is significantly higher than that of random guess and the rule-based method SyGMa. The results demonstrated that our method has a certain predictive ability and application value.
format Online
Article
Text
id pubmed-7003989
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70039892020-02-20 Deep Learning Based Drug Metabolites Prediction Wang, Disha Liu, Wenjun Shen, Zihao Jiang, Lei Wang, Jie Li, Shiliang Li, Honglin Front Pharmacol Pharmacology Drug metabolism research plays a key role in the discovery and development of drugs. Based on the discovery of drug metabolites, new chemical entities can be identified and potential safety hazards caused by reactive or toxic metabolites can be minimized. Nowadays, computational methods are usually complementary tools for experiments. However, current metabolites prediction methods tend to have high false positive rates with low accuracy and are usually only used for specific enzyme systems. In order to overcome this difficulty, a method was developed in this paper by first establishing a database with broad coverage of SMARTS-coded metabolic reaction rule, and then extracting the molecular fingerprints of compounds to construct a classification model based on deep learning algorithms. The metabolic reaction rule database we built can supplement chemically reasonable negative reaction examples. Based on deep learning algorithms, the model could determine which reaction types are more likely to occur than the others. In the test set, our method can achieve the accuracy of 70% (Top-10), which is significantly higher than that of random guess and the rule-based method SyGMa. The results demonstrated that our method has a certain predictive ability and application value. Frontiers Media S.A. 2020-01-30 /pmc/articles/PMC7003989/ /pubmed/32082146 http://dx.doi.org/10.3389/fphar.2019.01586 Text en Copyright © 2020 Wang, Liu, Shen, Jiang, Wang, Li and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Disha
Liu, Wenjun
Shen, Zihao
Jiang, Lei
Wang, Jie
Li, Shiliang
Li, Honglin
Deep Learning Based Drug Metabolites Prediction
title Deep Learning Based Drug Metabolites Prediction
title_full Deep Learning Based Drug Metabolites Prediction
title_fullStr Deep Learning Based Drug Metabolites Prediction
title_full_unstemmed Deep Learning Based Drug Metabolites Prediction
title_short Deep Learning Based Drug Metabolites Prediction
title_sort deep learning based drug metabolites prediction
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003989/
https://www.ncbi.nlm.nih.gov/pubmed/32082146
http://dx.doi.org/10.3389/fphar.2019.01586
work_keys_str_mv AT wangdisha deeplearningbaseddrugmetabolitesprediction
AT liuwenjun deeplearningbaseddrugmetabolitesprediction
AT shenzihao deeplearningbaseddrugmetabolitesprediction
AT jianglei deeplearningbaseddrugmetabolitesprediction
AT wangjie deeplearningbaseddrugmetabolitesprediction
AT lishiliang deeplearningbaseddrugmetabolitesprediction
AT lihonglin deeplearningbaseddrugmetabolitesprediction